BCV
WST icon

Banque Cantonale Vaudoise’s West Pharmaceutical WST Stock Holding History

Banque Cantonale Vaudoise’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88K Buy
+353
New +$87.8K ﹤0.01% 731
2025
Q3 		– Sell
-6,501
Closed -$1.42M – 867
2025
Q2 		$1.42M Buy
6,501
+835
+15% +$179K 0.06% 302
2025
Q1 		$1.27M Buy
+5,666
New +$1.56M 0.06% 309
2024
Q3 		$813K Sell
2,707
-5,066
-65% -$1.55M 0.03% 343
2024
Q2 		$2.56M Buy
7,773
+1,691
+28% +$598K 0.1% 195
2024
Q1 		$2.41M Sell
6,082
-26
-0.4% -$9.62K 0.09% 219
2023
Q4 		$2.15M Buy
6,108
+2,574
+73% +$911K 0.09% 220
2023
Q3 		$1.33M Sell
3,534
-667
-16% -$258K 0.07% 253
2023
Q2 		$1.61M Buy
4,201
+2,301
+121% +$822K 0.08% 230
2023
Q1 		$659K Hold
1,900
– – 0.03% 393
2022
Q4 		$447K Hold
1,900
– – 0.02% 473
2022
Q3 		$467K Hold
1,900
– – 0.03% 494
2022
Q2 		$575K Sell
1,900
-600
-24% -$195K 0.03% 459
2022
Q1 		$1.03M Hold
2,500
– – 0.04% 382
2021
Q4 		$1.17M Sell
2,500
-3,681
-60% -$1.58M 0.05% 379
2021
Q3 		$2.62M Buy
6,181
+1,738
+39% +$733K 0.11% 177
2021
Q2 		$1.59M Buy
4,443
+1,643
+59% +$543K 0.07% 292
2021
Q1 		$789K Sell
2,800
-1,500
-35% -$429K 0.04% 429
2020
Q4 		$1.22M Hold
4,300
– – 0.07% 259
2020
Q3 		$1.18M Sell
4,300
-200
-4% -$52.9K 0.08% 230
2020
Q2 		$1.02M Sell
4,500
-6,500
-59% -$1.28M 0.07% 267
2020
Q1 		$1.67M Buy
11,000
+3,200
+41% +$493K 0.14% 151
2019
Q4 		$1.17M Buy
+7,800
New +$1.14M 0.08% 263

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Cantonale Vaudoise's WST Position: Q1 2026 in Review

Banque Cantonale Vaudoise opened a new position in West Pharmaceutical (WST) in Q1 2026: 353 shares worth $88K. The stake represents ﹤0.01% of the portfolio and ranks #731 among its holdings. This is a return to the name: Banque Cantonale Vaudoise previously reported a position in WST as recently as Q2 2025.

Banque Cantonale Vaudoise first reported a position in WST in Q4 2019 and has held it in 23 quarters since. The position peaked at $2.62M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Banque Cantonale Vaudoise held 353 shares of West Pharmaceutical worth $88K as of Q1 2026.
  • West Pharmaceutical was a new Banque Cantonale Vaudoise position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #731 holding.
  • Banque Cantonale Vaudoise first reported a position in West Pharmaceutical in Q4 2019 and has held it in 23 quarters since.
  • Banque Cantonale Vaudoise's West Pharmaceutical position peaked at $2.62M in Q3 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.